FEMALE CARE PRODUCTS LOADED WITH TOXICS
TURMERIC MOUTHWASH SHOWN SUPERIOR TO CHLOREXIDINE
STEVIA REDUCES BLOOD PRESSURE
SCIENCE CONFIRMS TURMERIC AS EFFECTIVE AS 14 DRUGS
SUCRALOSE = SPLENDA LINKED TO LEUKEMIA, DIABETES, BAKED INTO DIOXINS.
GLUTEN SENSITIVITY LINKED TO GMO FOODS
HEALTH STATISTICS OVERVIEW
FEMALE CARE PRODUCTS LOADED WITH TOXICS
Tampons are used by up to 85 percent of menstruating women and may contain dioxins or pesticide residues linked to cancer, hormone disruptors, allergens and irritants from fragrance, WVE said. Feminine wipes, feminine washes and feminine deodorant products contain toxic preservatives like parabens, which may be hormone disruptors, or quaternium-15 and DMDM hydantoin, which release cancer-causing formaldehyde. Most feminine care products are fragranced and commonly contain known fragrance allergens—including anti-itch products. These chemicals sometimes exacerbate the very symptoms a woman is attempting to self-treat with these products.
Potential HealtH Hazards associated
witH feminine care Products
Tampons: Hazardous ingredients may include dioxins and furans (from the chlorine bleaching process), pesticide residues and unknown fragrance chemicals. Exposure concerns include cancer, reproductive harm, endocrine disruption, and allergic rash.
Pads: Hazardous ingredients may include dioxins and furans, pesticide residues, unknown fragrance chemicals, and adhesive chemicals such as methyldibromo glutaronitrile. exposure concerns include cancer, reproductive harm, and endocrine disruption. studies link pad use to allergic rash.
Feminine Wipes: Hazardous ingredients may include methylchloroisothiazolinone, methylisothiazolinone, parabens, quaternium-15, dmdm Hydantoin and unknown fragrance chemicals. exposure concerns include cancer and endocrine disruption. studies link wipe use to allergic rash.
Feminine Wash: Hazardous ingredients may
include unknown fragrance chemicals, parabens,
methylchloroisothiazolinone, methylisothiazolinone, dmdm Hydantoin, d&c red no.33, ext d&c violet #2, and fd&c yellow #5. exposure concerns include endocrine disruption, allergic rash, and asthma.
Douche: Hazardous ingredients may include unknown fragrance chemicals and the spermicide octoxynol-9. Studies link douche use to bacterial vaginosis, pelvic inflammatory disease, cervical cancer, low-birth weight, preterm birth, Hiv transmission, sexually transmitted diseases, ectopic pregnancy, chronic yeast infections, and infertility.
Feminine deodorant (sprays , powders and
suppositories): Hazardous ingredients may include unknown fragrance chemicals, parabens, and benzethonium chloride. exposure concerns include reproductive harm, endocrine disruption and allergic rash.
Feminine anti-itch creams: Hazardous ingredients may include unknown fragrance chemicals, parabens, methylisothiazolinone and an active ingredient, benzocaine, a mild anesthetic. exposure concerns include endocrine disruption, allergic rash, and uunresolved itch.
Vulvar and vaginal tissue are structurally different than the skin of the rest
of the body. For example, these tissues are also more hydrated and more permeable than other skin. That means this area of the body is potentially more vulnerable to exposure to toxic chemicals and irritants.7 In addition,
the inner parts of the vulva and the vagina
are covered in mucous membranes, which
serve an immune defense function, creating
a barrier against pathogens which could lead
to disease.8 The walls of the vagina are filled
with numerous blood vessels and lymphatic
vessels, which allows for direct transfer of
chemicals in to the circulatory system.9
In fact, there is considerable interest in
vaginal drug delivery systems because the
vagina is such an effective site to transfer
drugs directly into the blood without being
SUCRALOSE = SPLENDA LINKED TO LEUKEMIA, DIABETES, BAKED INTO DIOXINS.
A new, in-depth review on the synthetic sweetener sucralose (marketed as Splenda), published in the journal of Toxicology and Environmental Health, is destined to overturn widely held misconceptions about the purported safety of this ubiquitous artificial sweetener.
Found in tens of thousands of products and used by millions of consumers around the world, sucralose’s unique ability to dissolve in alcohol and methanol as well as water, makes it the most versatile and therefore most widely used artificial sweetener in production today. And yet, its popularity is no indication nor guarantee of its safety, as is evidenced by the widespread use of other artificial sweeteners like aspartame, which while being safety approved in 90 nations around the world, has been linked to a wide range of serious health conditions including brain damage.
But the tide may be turning…
Already this year, the Center for the Public Interest in Science downgraded Splenda from “safe” to “caution,” citing their need to evaluate a forthcoming Italian study linking the artificial sweetener to leukemia in mice as a basis for their decision.
Another recent human study linked Splenda to diabetes-associated changes, calling into question its value as a non-calorie sweetener for those suffering with, or wishing to prevent, blood sugardisorders.
The new study, however, may be the most concerning yet to surface in the peer-reviewed literature. Titled, “Sucralose, a synthetic organochlorine sweetener: overview of biological issues,” it reveals an extensive array of hitherto underreported safety concerns, not the least of which is theformation of highly toxic chlorinated compounds, including dioxins, when Splenda is used in baking, an application which its manufacturer, McNeil Nutritionals (a subsidiary of Johnson & Johnson), actively encourages it to be used for. [see: Cooking and Baking: SPLENDA®]
Sucralose is a toxic chemical that we should go to great lengths to avoid exposure to rather than something we should intentionally add to our food. You will also find a growing body of research that indicates that sucralose not only does not break down in the environment, but survives water treatment plant purification techniques, with the inevitable consequence that it is accumulating in concentrations in our drinking water and the environment that may adversely impact humans and wildlife alike.
Research is showing that sucralose can break down into the following concerning compounds when heated:
- · Chloropopanols are generated when sucralose was heated in the presence of glycerol. Chloropopanols are a group of contaminants that include known genotoxic, carcinogenic and tumorigenic compounds.
- · Other chlorinated compounds formed when sucralose is heated in the presence of food include dibenzo-p-dioxins, dibenzofurans, dioxin-like polychlorinated bisphenyls and polychlorinated naphthalenes.
Chlorinated compounds like dioxins and DDT are notorious for being both highly toxic and resistant to breaking down once released into the environment, which is why they are classified as ‘persistent organic pollutants.’
The discovery that thermal breakdown through cooking can lead to the formation of highly toxic and equally persistent chlorinated compounds, including dioxins, should raise a series of red flags for consumers, manufacturers and regulators as the information becomes more widespread. A cursory perusal of the World Health Organization’s description of ‘Dioxins and their effects on human health,’ which lists it as belonging to the “dirty dozen” of the world’s most dangerous pollutants, will see what is at stake here. For more information on the formation of toxic chlorinated byproducts following the heating of sucralose read a 2013 study published in Scientific Reports titled, “Polychlorinated dibenzo-p-dioxins and dibenzofurans formed from sucralose at high temperatures,” which goes into the topic in greater depth.
The Acceptable Daily Intake of Splenda (Sucralose) May Have Been Set 100’s of Times Too High To Ensure Safety
Lastly, an equally concerning issue addressed by the paper is the problem of the acceptable daily intake (ADI). The FDA approved an ADI for humans of 5 mg/kg/day in 1998 based on toxicity studies in rats by determining a no-observed-effect level (NOEL) of 500 mg/kg/day, and then applying a 100-fold safety factor. Since then, research has emerged showing that the NOEL in the microbiome (‘gut bacteria’) of rats for Splenda is actually as low as 1.1 mg/kg/day – 454 times lower than first determined – and 3.3 mg/kg/day for changes in intestinal P-gp and CYP – 151 times lower than first determined.
For additional research on sucralose’s adverse health effects, visit our research page that collates peer-reviewed research on its toxicological properties. Also, for research on natural sweeteners not associated with these adverse effects, take a look at the following alternatives:
STEVIA REDUCES BLOOD PRESSURE
Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study.
Clin Ther. 2003 Nov;25(11):2797-808. PMID: 14693305
Ming-Hsiung Hsieh, Paul Chan, Yuh-Mou Sue, Ju-Chi Liu, Toong Hua Liang, Tsuei-Yuen Huang, Brian Tomlinson, Moses Sing Sum Chow, Pai-Feng Kao, Yi-Jen Chen
Department of Medicine, Taipei Medical University–Wan Fang Hospital, Taipei City, Taiwan.
BACKGROUND: Stevioside, a natural glycoside isolated from the plant Stevia rebaudiana Bertoni, has been used as a commercial sweetening agent in Japan and Brazil for>20 years. Previous animal and human studies have indicated that stevioside has an antihypertensive effect.
OBJECTIVES: This study was undertaken to investigate the long-term (2-year) efficacy and tolerability of stevioside in patients with mild essential hypertension. Secondary objectives were to determine the effects of stevioside on left ventricular mass index (LVMI) and quality of life (QOL).
METHODS: This was a multicenter, randomized, double-blind, placebo-controlled trial in Chinese men and women aged between 20 and 75 years with mild essential hypertension (systolic blood pressure [SBP] 140-159 mm Hg and diastolic blood pressure [DBP] 90-99 mm Hg). Patients took capsules containing 500 mg stevioside powder or placebo 3 times daily for 2 years. Blood pressure was measured at monthly clinic visits; patients were also encouraged to monitor blood pressure at home using an automated device. LVMI was determined by 2-dimensional echocardiography at baseline and after 1 and 2 years of treatment. QOL was assessed using the Medical Outcomes Study 36-Item Short-Form Health Survey. Electrocardiographic, laboratory, and QOL parameters were assessed at the beginning of treatment, and at 6 months, 1 year, and 2 years.
RESULTS: One hundred seventy-four patients (87 men, 87 women) were enrolled in the study, and 168 completed it: 82 (42 men, 40 women; mean [SD] age, 52  years) in the stevioside group and 86 (44 women, 42 men; mean age, 53  years) in the placebo group. After 2 years, the stevioside group had significant decreases in mean (SD) SBP and DBP compared with baseline (SBP, from 150 [7.3] to 140 [6.8] mm Hg; DBP, from 95 [4.2] to 89 [3.2] mm Hg; P<0.05) and compared with placebo (P<0.05). Based on patients’ records of self-monitored blood pressure, these effects were noted beginning approximately 1 week after the start of treatment and persisted throughout the study. There were no significant changes in body mass index or blood biochemistry, and the results of laboratory tests were similar in the 2 groups throughout the study. No significant difference in the incidence of adverse effects was noted between groups, and QOL scores were significantly improved overall with stevioside compared with placebo (P<0.001). Neither group had a significant change in mean LVMI. However, after 2 years, 6 of 52 patients (11.5%) in the stevioside group had left ventricular hypertrophy (LVH), compared with 17 of 50 patients (34.0%) in the placebo group (P<0.001). Of those who did not have LVH at baseline, 3 of 46 patients (6.5%) in the stevioside group had developed LVH after 2 years, compared with 9 of 37 patients (24.3%) in the placebo group (P<0.001).
CONCLUSIONS: In this 2-year study in Chinese patients with mild hypertension, oral stevioside significantly decreased SBP and DBP compared with placebo. QOL was improved, and no significant adverse effects were noted.
Science Confirms Turmeric As Effective As 14 Drugs
Monday, May 13th 2013 at 2:00 pm
Turmeric is one the most thoroughly researched plants in existence today. Its medicinal properties and components (primarily curcumin) have been the subject of over 5600 peer-reviewed and published biomedical studies. In fact, our five-year long research project on this sacred plant has revealed over 600 potential preventive and therapeutic applications, as well as 175 distinct beneficial physiological effects. This entire database of 1,585 ncbi-hyperlinked turmeric abstracts can be downloaded as a PDF at our Downloadable Turmeric Document page, and acquired either as a retail item or with 200 GMI-tokens, for those of you who are already are members and receive them automatically each month.
Given the sheer density of research performed on this remarkable spice, it is no wonder that a growing number of studies have concluded that it compares favorably to a variety of conventional medications, including:
- · Lipitor/Atorvastatin(cholesterol medication): A 2008 study published in the journal Drugs in R & D found that a standardized preparation of curcuminoids from Turmeric compared favorably to the drug atorvastatin (trade name Lipitor) on endothelial dysfunction, the underlying pathology of the blood vessels that drives atherosclerosis, in association with reductions in inflammation and oxidative stress in type 2 diabetic patients. [i] [For addition curcumin and ‘high cholesterol’ research – 8 abstracts]
- · Corticosteroids (steroid medications): A 1999 study published in the journal Phytotherapy Research found that the primary polyphenol in turmeric, the saffron colored pigment known ascurcumin, compared favorably to steroids in the management of chronic anterior uveitis, an inflammatory eye disease.[ii] A 2008 study published in Critical Care Medicine found thatcurcumin compared favorably to the corticosteroid drug dexamethasone in the animal model as an alternative therapy for protecting lung transplantation-associated injury by down-regulating inflammatory genes.[iii] An earlier 2003 study published in Cancer Letters found the same drug also compared favorably to dexamethasone in a lung ischaemia-repurfusion injury model.[iv] [for additional curcumin and inflammation research – 52 abstracts]
- · Prozac/Fluoxetine & Imipramine (antidepressants): A 2011 study published in the journalActa Poloniae Pharmaceutica found that curcumin compared favorably to both drugs in reducing depressive behavior in an animal model.[v] [for additional curcumin and depression research – 5 abstracts]
- · Aspirin (blood thinner): A 1986 in vitro and ex vivo study published in the journalArzneimittelforschung found that curcumin has anti-platelet and prostacyclin modulating effects compared to aspirin, indicating it may have value in patients prone to vascular thrombosis and requiring anti-arthritis therapy.[vi] [for additional curcumin and anti-platelet research]
- · Anti-inflammatory Drugs: A 2004 study published in the journal Oncogene found that curcumin (as well as resveratrol) were effective alternatives to the drugs aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in exerting anti-inflammatory and anti-proliferative activity against tumor cells.[vii] [for additional curcumin and anti-proliferative research – 15 abstracts]
- · Oxaliplatin (chemotherapy drug): A 2007 study published in the International Journal of Cancer found that curcumin compares favorably with oxaliplatin as an antiproliferative agenet in colorectal cell lines.[viii] [for additional curcumin and colorectal cancer research – 52 abstracts]
- · Metformin (diabetes drug): A 2009 study published in the journal Biochemitry and Biophysical Research Community explored how curcumin might be valuable in treating diabetes, finding that it activates AMPK (which increases glucose uptake) and suppresses gluconeogenic gene expression (which suppresses glucose production in the liver) in hepatoma cells. Interestingly, they found curcumin to be 500 times to 100,000 times (in the form known as tetrahydrocurcuminoids(THC)) more potent than metformin in activating AMPK and its downstream target acetyl-CoA carboxylase (ACC). [ix]
TURMERIC MOUTHWASH SHOWN SUPERIOR TO CHLOREXIDINE
In 2012, a study published in the Journal of Indian Society of Periodontology compared the efficacy of a .1% curcumin extract mouthwash + .01% eugenol (Group A) to a more strongly concentrated .2% chlorhexidine gluconate mouthwash (Group B), in subjects with mild to moderate gingivitis. Both Group A and Group B consisted of 30 subjects who were advised to use 10 ml of mouthwash with equal dilution of water for 1 min twice a day 30 min after brushing. They were then tracked for plaque and gingival changes at day 0, day 14h and day 21. Both their direct experience (subjective) and objective criteria were assessed at days 14 and 21.
The results were as follows:
On comparison between chlorhexidine and turmeric mouthwash, percentage reduction of the Plaque Index between 0 and 21 st day were 64.207 and 69.072, respectively (P=0.112), percentage reduction of Gingival Index between 0 and 21st day were 61.150 and 62.545 respectively (P=0.595) and percentage reduction of BAPNA [The N-benzoyl-l-arginine-p- nitroanilide assay; a measurement of pathogenic bacterial activity] values between 0 and 21st day were 42.256 and 48.901 respectively (P=0.142). [emphasis added]
In all three objective parameters tested, turmeric extract was at least as effective as chlorhexidine mouthwash at improving the patient’s oral health. However, technically, the curcuminformulation beat out the chemical mouthwash in all 3 measurements, and at only one-half the concentration.
GLUTEN SENSITIVITY LINKED TO GMO FOODS
Wheat is not a genetically modified organism (GMO). But evidence suggests that genetically modified foods, such as soy and corn, may help explain the recent explosion of gluten-related disorders, which now affect up to 18 million Americans.
The best way to avoid GMOs is to consult the NonGMOShoppingGuide.com or download thefree iPhone app ShopNoGMO. Look for products with either the “Non-GMO Project Verified” or the “Certified Organic” seal. Avoid ingredients derived from the foods most likely to be genetically modified. These include soy, corn, cottonseed, canola, sugar, papaya from Hawaii or China, zucchini, and yellow squash.
Another possible environmental trigger may be the introduction of genetically modified organisms (GMOs) to the American food supply, which occurred in the mid-1990s. GMOs are created by a laboratory process that transfers genetic material into the DNA of an organism. There are nine genetically modified (GM) food crops currently on the market: soy, corn, cotton (oil), canola (oil), sugar from sugar beets, zucchini, yellow squash, Hawaiian papaya, and alfalfa. Notice that wheat is not one of these. Although wheat has been hybridized through natural breeding techniques over the years, it isnot in fact a GMO.
Most GM crops are engineered to tolerate a weed killer called Roundup®, whose active ingredient is glyphosate. These crops, known as Roundup-Ready crops, accumulate high levels of glyphosate that remain in the food. Corn and cotton varieties are also engineered to produce an insecticide called Bt-toxin. The Bt-toxin is produced in every cell of genetically engineered corn and ends up in corn chips, corn tortillas, and other ingredients derived from corn. A recent analysis of research suggests that Bt-toxin, glyphosate, and other components of GMOs, are linked to five conditions that may either initiate or exacerbate gluten-related disorders:
- Intestinal permeability
- Imbalanced gut bacteria
- Immune activation and allergies
- Impaired digestion
- Damage to the intestinal wall
Health Statistics Overview (from same source as above).
Yes, it’s true that people are living longer than ever but I wouldn’t say they are arriving in style.
- · 50% of people over 60 years old are on 5 or more pharmaceutical drugs
- · The United States is ranked 38th in lifespan among all countries despite outspending all of them by large margins on health care.
- · 50% of Americans will have cataracts by the age of eighty
- · Based on a study from 2009, Nearly half of people aged 85 and older (43 percent) have Alzheimer’s disease.
- · Digestive disease affects 3 in 4 people over age 45.
- · Most persons over the age of 75 are affected with osteoarthritis in at least one joint, making this condition a leading cause of disability in the US
Take a look at some recent headlines:
- 1. Dementia cases ‘to double by 2030′ says World Health Organisation
- 2. 100 Million Plus in Chronic Pain in U.S.
- 3. Fat Future: 42% of Americans May Be Obese by 2030
- 4. U.S. autism rates reach new height – CDC
- 5. CDC: More American Adults Hobbled by Arthritis
- 6. Osteoporosis on the Rise in the U.S.
- 7. Global cancer cases to rise 75 pct by 2030 as developing countries adopt bad habits from West
- 8. Federal Centers for Disease Control and Prevention study finds an alarming increase in Type 2 diabetes and pre-diabetes among adolescents age 12 to 19
- 9. Type 2 Diabetes Rates Rising Around the World
- 10. Almost 3/4 of the Nation is Overweight…
- 11. Reports of Acid Reflux Symptoms Double, Study Finds
- 12. Liver disease deaths ‘up by 25%’
- 13. U.S. asthma rates at all-time high, CDC says
- 14. Strokes in Children and Young Adults on the Rise Researchers Say Findings Should Be a Wake-Up Call for Lifestyle Improvements
- 15. 40% New York City children either obese or overweight
- 16. Eye diseases rising at rapid rates in U.S.
- 17. Deadly strain of MRSA now resistant to last-line antibiotics for infections
- 18. High Blood Pressure a Rising Risk for Kids, Teens
- 19. Diabetes now affects nearly 20 percent of the U.S. population.
- 20. In 2010, according to WHO, there are an estimated 42 million children under five years old who are overweight, and this figure is increasing at an alarming rate.
- 21. By 2050, the worldwide incidence of hip fracture in men is projected to increase by 240% in women and 310% in men.
- 22. 50 million US adults (or 22 percent of the population) have arthritis
- 23. One in 2 people will develop osteoarthritis during their lifetime
- 24. More than 40 million people in the US have some form of arthritis (one in every six people)
Over the last 30 years their have been increases in the rates for Obesity, Diabetes, Autism, Asthma, ADHD,Food Allergies, Acid Reflux, Alezheimers, Back Pain, Cancer(all types combined), Celiac disease, Chronic fatigue, Chronic Obstructive Pulminary Disease, Gout, High Blood Pressure, Kidney Stones, Lupus, Migraines, Rheumatoid Arthritis, Septicemica, Depression, Cardiovascular Disease, Bipolar Disorder, Dementia. Hypertension, GERD, Strokes and Migraines. Despite all the great technology and all the great inventions, the health of people and the environment has never been more threatened.
Excerpts from Recent News Stories:
- 1. Scientists Paid to Promote Junk Food
- 2. Bias Can Exaggerate Drugs’ Effectiveness
- 3. Half of U.S. Corporations in Study Skewed Climate Science
- 4. Strides in Scientific Integrity at FDA Hindered by Special Interests
- 5. FDA’s Huge Conflicts of Interest with Big Pharma
- 6. Big Pharma Routinely Suppresses Data from Clinical Trials—but FDA Approves These Dangerous Drugs Anyway!
- 7. Organic Food Advocates Condemn USDA’s Cozy Relationship With Corporate Agribusiness
- 8. Funding the American Diabetes Association
- 9. MIT’s Fracking Report Backs Its Donors: Gas Companies
- 10. Harvard To Be Tried for Alzheimer’s Research Fraud
- 11. 70% of DSM Psychiatrists Financially Tied to Drug Companies
- 12. Think the drugs your GP gives you are safe? Well, don’t be so sure
- 13. Secret Clinical Trial Data is a Bonanza for Big Pharma but a Risk to Your Health
- 14. US Advisory Group on Fracking Has Abundant Ties to Energy Industry
- 15. Methyl Iodide Controversy: California Officials Ignored Scientists In Approving Dangerous Pesticide
- 16. Why is Massive Conflict of Interest Allowed in Government Health Recommendations?
- 17. Statin Drugs Shown to Increase Risk of Diabetes Significantly — Yet the Media Scramble to Protect the Drugs’ Reputation